208 related articles for article (PubMed ID: 19813543)
1. [Anticoagulation in atrial fibrillation. Stroke can be prevented this way].
Thorsten L
MMW Fortschr Med; 2009 Sep; 151(36):53. PubMed ID: 19813543
[No Abstract] [Full Text] [Related]
2. [Stroke prevention in atrial fibrillation. Marcumar alternative in sight].
Einecke D
MMW Fortschr Med; 2009 Sep; 151(38):12-4. PubMed ID: 19831172
[No Abstract] [Full Text] [Related]
3. [Prevention of stroke in atrial fibrillation].
Masjuan J
Neurologia; 2012 Mar; 27 Suppl 1():1-3. PubMed ID: 22682203
[No Abstract] [Full Text] [Related]
4. [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
Geisler T; Gawaz M
MMW Fortschr Med; 2011 Apr; 153(15):27-30; quiz 31. PubMed ID: 21667556
[No Abstract] [Full Text] [Related]
5. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice. Care of patients receiving long-term anticoagulant therapy.
Schulman S
N Engl J Med; 2003 Aug; 349(7):675-83. PubMed ID: 12917305
[No Abstract] [Full Text] [Related]
7. Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial.
Paikin JS; Haroun MJ; Eikelboom JW
Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):279-86. PubMed ID: 21438804
[TBL] [Abstract][Full Text] [Related]
8. [Limitations of anticoagulant therapy].
Martí-Fàbregas J; Delgado-Mederos R; Mateo J
Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
[TBL] [Abstract][Full Text] [Related]
9. [What is the current use of vitamin K antagonists in the elderly?].
Vidal JS; Hanon O
Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):17-22. PubMed ID: 24463060
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S;
Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of cardioembolic stroke].
Gil Núñez A
Neurologia; 2012 Mar; 27 Suppl 1():15-26. PubMed ID: 22682206
[TBL] [Abstract][Full Text] [Related]
12. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Apostolakis S; Shantsila E; Lip GY; Lane DA
Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
[No Abstract] [Full Text] [Related]
13. Stroke prevention in atrial fibrillation: do we still need warfarin?
Diener HC; Weber R; Lip GY; Hohnloser SH
Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran etexilate (Pradaxa) for the treatment of atrial fibrillation.
Belavic JM
Nurse Pract; 2011 Sep; 36(9):6-7. PubMed ID: 21857210
[No Abstract] [Full Text] [Related]
15. Warfarin for stroke prevention in atrial fibrillation: time to switch?
Ahmad Y; Lip GY
Int J Clin Pract; 2013 Jul; 67(7):603-5. PubMed ID: 23758442
[No Abstract] [Full Text] [Related]
16. [Anticoagulation and atrial fibrillation].
Simmers TA
Tijdschr Gerontol Geriatr; 2012 Dec; 43(6):308-12. PubMed ID: 23371873
[TBL] [Abstract][Full Text] [Related]
17. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
18. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Tripodi A; Palareti G
J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
[TBL] [Abstract][Full Text] [Related]
19. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
20. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
